Bank of New York Mellon Corp cut its holdings in shares of Abrdn Healthcare Investors (NYSE:HQH – Free Report) by 29.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,002 shares of the financial services provider’s stock after selling 10,000 shares during the quarter. Bank of New York Mellon Corp’s holdings in Abrdn Healthcare Investors were worth $419,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in the business. Quantedge Capital Pte Ltd lifted its holdings in Abrdn Healthcare Investors by 42.5% during the fourth quarter. Quantedge Capital Pte Ltd now owns 209,600 shares of the financial services provider’s stock valued at $3,473,000 after purchasing an additional 62,500 shares during the last quarter. Raymond James & Associates increased its position in shares of Abrdn Healthcare Investors by 0.9% during the second quarter. Raymond James & Associates now owns 197,587 shares of the financial services provider’s stock valued at $3,450,000 after buying an additional 1,847 shares during the period. Cetera Investment Advisers increased its position in shares of Abrdn Healthcare Investors by 46.8% during the first quarter. Cetera Investment Advisers now owns 177,208 shares of the financial services provider’s stock valued at $2,988,000 after buying an additional 56,521 shares during the period. Janney Montgomery Scott LLC increased its position in shares of Abrdn Healthcare Investors by 3.5% during the first quarter. Janney Montgomery Scott LLC now owns 162,986 shares of the financial services provider’s stock valued at $2,748,000 after buying an additional 5,489 shares during the period. Finally, Cetera Advisors LLC bought a new stake in shares of Abrdn Healthcare Investors during the first quarter valued at about $1,974,000. 32.60% of the stock is owned by hedge funds and other institutional investors.
Abrdn Healthcare Investors Trading Down 1.2 %
Shares of HQH opened at $18.71 on Wednesday. The business’s 50-day moving average price is $18.81 and its 200-day moving average price is $17.55. Abrdn Healthcare Investors has a twelve month low of $14.31 and a twelve month high of $19.79.
Abrdn Healthcare Investors Dividend Announcement
Abrdn Healthcare Investors Profile
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Read More
- Five stocks we like better than Abrdn Healthcare Investors
- What is a Secondary Public Offering? What Investors Need to Know
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is Short Interest? How to Use It
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What Does a Stock Split Mean?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.